540686 Stock Overview
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
NewNotes are coming soon
Smruthi Organics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹162.25 |
| 52 Week High | ₹311.00 |
| 52 Week Low | ₹145.20 |
| Beta | 1.33 |
| 1 Month Change | -5.20% |
| 3 Month Change | -23.88% |
| 1 Year Change | -44.26% |
| 3 Year Change | 302.11% |
| 5 Year Change | 469.30% |
| Change since IPO | 179.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540686 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.4% | -1.8% | -3.7% |
| 1Y | -44.3% | -7.6% | -2.2% |
Return vs Industry: 540686 underperformed the Indian Pharmaceuticals industry which returned -7.6% over the past year.
Return vs Market: 540686 underperformed the Indian Market which returned -2.2% over the past year.
Price Volatility
| 540686 volatility | |
|---|---|
| 540686 Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 3.3% |
Stable Share Price: 540686 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 540686's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 290 | Purushotham Eaga | https://www.smruthiorganics.com |
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India. It API products include amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan for cardiovascular; metformin HCL, teneligliptin, dapagliflozin, and vildagliptin for anti-diabetic; ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate for anti-infective applications; and ticagrelor for anti-platelets. The company also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine, as well as bulk drugs.
Smruthi Organics Limited Fundamentals Summary
| 540686 fundamental statistics | |
|---|---|
| Market Cap | ₹1.86b |
| Earnings (TTM) | ₹81.66m |
| Revenue (TTM) | ₹1.44b |
22.7x
P/E Ratio1.3x
P/S RatioIs 540686 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540686 income statement (TTM) | |
|---|---|
| Revenue | ₹1.44b |
| Cost of Revenue | ₹898.89m |
| Gross Profit | ₹543.73m |
| Other Expenses | ₹462.07m |
| Earnings | ₹81.66m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 09, 2023
| Earnings per share (EPS) | 7.13 |
| Gross Margin | 37.69% |
| Net Profit Margin | 5.66% |
| Debt/Equity Ratio | 8.3% |
How did 540686 perform over the long term?
See historical performance and comparison